Clostridium Botulinum Infections - Pipeline Review, H2 2012 New Report
Clostridium Botulinum Infections - Pipeline Review, H2 2012, provides an overview of the Clostridium Botulinum Infections therapeutic pipeline. This report provides information on the therapeutic development for Clostridium Botulinum Infections, complete with latest updates, and special features on late-stage and discontinued projects. It also reviews key players involved in the therapeutic development for Clostridium Botulinum Infections. 'Clostridium Botulinum Infections - Pipeline Review, H2 2012' is built using data and information sourced from Global Markets Direct’s proprietary databases, Company/University websites, SEC...
View full press release